CR Medical (01515): Fang Xin Joins Board as Non-Executive Director, Replacing Retiring Ge Lu

Bulletin Express03-11

China Resources Medical Holdings Company Limited (CR Medical, 01515) announced that, effective 11 March 2026, Ms. Ge Lu has retired as a non-executive director and member of the Remuneration Committee, and Mr. Fang Xin has been appointed to both positions.

Ms. Ge confirmed no disagreement with the board and no matters requiring shareholder or Hong Kong Stock Exchange attention. The board formally thanked her for her contributions.

Mr. Fang, aged 50, is currently a director of China Resources Healthcare Group Limited and an external director at China Resources (Holdings) Company Limited business units. His past roles include: • Non-executive director, China Resources Vanguard (Holding) Company Limited (since February 2025) • Non-executive director, China Resources Gas Group Limited (1193 HK) (since January 2025) • General manager, China Resources Chemical Innovative Materials Co., Ltd. (301090 SZ), January 2022 – December 2024

Fang joined China Resources Group in August 1996 and has held multiple senior positions across its chemical businesses. He holds a bachelor’s degree in engineering from Beijing Institute of Technology.

The new director has signed a three-year service agreement running from 11 March 2026 to 10 March 2029. He will receive no remuneration for his non-executive role and is subject to retirement by rotation and re-election at the company’s annual general meeting.

As of the announcement date, Fang holds indirect interests in approximately 101,265 shares of China Resources Chemical Innovative Materials Co., Ltd. and 20,000 shares of China Resources Power Holdings Company Limited (0836 HK). He has no other interests in CR Medical or its associated corporations under Hong Kong’s Securities and Futures Ordinance and reports no additional directorships or relationships requiring disclosure under the Listing Rules.

Following the change, CR Medical’s board comprises four executive directors (Yu Hai, Zhang Chuang, Wang Yuexing, Wu Xinchun), one non-executive director (Fang Xin) and four independent non-executive directors (Wu Ting Yuk, Anthony; Fu Tingmei; Zhou Peng; Lo Wing Sze).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment